Food and Drug Administration (FDA)

A “complex” political environment presents both challenge and opportunity for the pro-life movement, said Jennie Bradley Lichter.

In a press call just before the 53rd annual March for Life, a key national pro-life organization pushed the Trump administration to safeguard the Hyde Amendment and reinstate stronger restrictions …

A Senate committee held a hearing on the abortion pill Jan. 14 as the Trump administration faces scrutiny from some pro-lifers over the Food and Drug Administration’s recent approval of …

U.S. Senate rejects dueling health care bills Dec. 11. The Democratic and GOP-led bills didn’t reach the chamber’s 60-vote filibuster threshold to advance. 

“The FDA is doing nothing while every single day abortion drugs take the lives of children, put women and girls at serious risk.”

The president of Susan B. Anthony Pro-Life America argued any action that further expands the use of the drugs commonly used for abortion is “irresponsible.”

The U.S. Supreme Court on Oct. 15 heard oral arguments over a Voting Rights Act provision and the White House drew attention to Down Syndrome Awareness Month.

Israel’s government ratified what the White House called the “first phase” of a ceasefire deal, as President Donald Trump indicated he planned to visit the region.

A new generic form of mifepristone, a pill commonly used for abortion, has been approved once again under a Trump administration, prompting pro-life outcry.

Food and Drug Administration Commissioner Martin Makary said April 24 he has “no plans” to restrict the availability of mifepristone, a pill commonly used for abortion.